Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Articles
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Service / Activity
Reset
1 / 124
1 / 124
In Situ Engineering
Engineering from Within via In Situ Programming and Regeneration
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-08
Jun 17, 2025
CLD
Advancing Biologics Development With Next-Generation Cell Line Development
Woo Chi, Ph.D.; Yingji Jin, Ph.D.; Jaeeun Kim
Samsung Biologics
PAO-06-25-CL-06
Jun 16, 2025
Nanoscale
Addressing Drug Delivery Challenges at the Nanoscale
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-25-NI-07
Jun 16, 2025
Marketing
What Biotech and Pharma Buyers Actually Care About and How to Market Accordingly
Emilee Kudla
Pharma's Almanac
PAO-06-25-NI-06
Jun 16, 2025
Clinical Diversity
Staying the Course: Sustaining Equity in Clinical Trials Amid Headwinds
Tegan Mead
Javara
PAO-06-25-CL-05B
Jun 12, 2025
Clinical Diversity
Redefining Access: Embedding Diversity into the Clinical Research Ecosystem
Tegan Mead
Javara
PAO-06-25-CL-05A
Jun 12, 2025
Biotechs
Five Biotechs Approaching Critical Milestones in 2025
April Stanley, MS MBA; Emilee Kudla
Nice Insight
PAO-06-25-NI-05
Jun 09, 2025
TPD
Five Small Biotechs to Watch: June 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-04
Jun 05, 2025
Gender
The Business Case for Gender-Inclusive Pharma: Why Equity Drives Innovation, Performance, and Profit
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-03
Jun 04, 2025
Oversight
All That Glitters Is Not Gold Standard Science
David Alvaro, Ph.D.; April Stanley, MS MBA; Sophie Lutter, Ph.D.
Pharma's Almanac
PAO-06-25-NI-02
Jun 04, 2025
Degradation
Beyond the Proteasome: Unlocking New Frontiers with AUTACs and LYTACs
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-25-NI-01
Jun 02, 2025
Inclusive Trials
Inclusive Trials Are Better Trials: Why Women’s Health Can’t Be a Footnote Anymore
Emilee Kudla
Pharma's Almanac
PAO-05-25-NI-13
May 30, 2025
Gender Bias
Sex Differences, Gender Biases: What Are We Really Studying in Preclinical Research?
Serene Lee
Nice Insight
PAO-05-25-NI-12
May 29, 2025
Neuroscience
Designer Control: DREADDs and the Next Generation of Targeted Neuromodulation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-11
May 29, 2025
Nanobodies
Therapeutic Nanobodies and Intrabodies Rewriting the Rules of Target Engagement
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-10
May 27, 2025
Pregnancy Research
The Other Data Gap: Reimagining Clinical Research to Include Pregnant and Lactating Women
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-09
May 23, 2025
Data Security
Prioritizing Data Security Through Digital Transformation in Biomanufacturing
John Atkinson
Fujifilm Biotechnologies
PAO-05-25-CL-04
May 23, 2025
Flexibility
Flexible CDMO Solutions — Reducing Risk and Accelerating Time to Market
Sheetal Muley, Ph.D.; Justin Lacombe, Ph.D.
Experic
PAO-04-25-CL-06
May 23, 2025
Gender Equity
Achieving Gender Equity Without Saying “Gender” or “Women”
Heather Harmon
Pharma's Almanac
PAO-05-25-NI-08
May 22, 2025
Wearables
Closing the Gender Gap in Digital Health and Wearable Technologies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-25-NI-07
May 19, 2025
